A public health collaboration for the surveillance of autism spectrum disorders
- PMID:17302648
- DOI: 10.1111/j.1365-3016.2007.00801.x
A public health collaboration for the surveillance of autism spectrum disorders
Abstract
Autism spectrum disorders (ASDs) represent a range of behavioural phenotypes defined by impaired development in social interaction, communication, imagination, and range of interests or behaviours. The aetiology and epidemiology of these serious developmental disabilities (DDs) are poorly understood. Estimates of the population prevalence of ASDs have varied widely within the US and abroad, with increasing estimates in most of the recent studies. In an effort to improve our understanding of the prevalence, population characteristics and public health impact of these conditions, the Centers for Disease Control and Prevention has funded a multi-site surveillance network for ASDs and other DDs that consists of programmes known as the Autism and Developmental Disabilities Monitoring (ADDM) network which conducts surveillance activities and the Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE) which also conducts surveillance in addition to special research studies related to the ASDs. This collaboration will be referred to hereafter as the ADDM Network. The ADDM Network is implementing a multiple-source surveillance programme to determine population prevalence and characteristics of ASDs and other DDs. This paper describes the collaborative efforts and explains the methods in developing this coordinated public health surveillance network to provide an ongoing source of high-quality data on ASDs.
Similar articles
- Evaluation of a methodology for a collaborative multiple source surveillance network for autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2002.Van Naarden Braun K, Pettygrove S, Daniels J, Miller L, Nicholas J, Baio J, Schieve L, Kirby RS, Washington A, Brocksen S, Rahbar H, Rice C; Centers for Disease Control and Prevention.Van Naarden Braun K, et al.MMWR Surveill Summ. 2007 Feb 9;56(1):29-40.MMWR Surveill Summ. 2007.PMID:17287716
- Public health monitoring of developmental disabilities with a focus on the autism spectrum disorders.Rice C, Schendel D, Cunniff C, Doernberg N.Rice C, et al.Am J Med Genet C Semin Med Genet. 2004 Feb 15;125C(1):22-7. doi: 10.1002/ajmg.c.30006.Am J Med Genet C Semin Med Genet. 2004.PMID:14755430Review.
- Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, six sites, United States, 2000.Autism and Developmental Disabilities Monitoring Network Surveillance Year 2000 Principal Investigators; Centers for Disease Control and Prevention.Autism and Developmental Disabilities Monitoring Network Surveillance Year 2000 Principal Investigators, et al.MMWR Surveill Summ. 2007 Feb 9;56(1):1-11.MMWR Surveill Summ. 2007.PMID:17287714
- Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008.Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators; Centers for Disease Control and Prevention.Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators, et al.MMWR Surveill Summ. 2012 Mar 30;61(3):1-19.MMWR Surveill Summ. 2012.PMID:22456193
- Healthcare for children with autism: the Autism Treatment Network.Coury D, Jones NE, Klatka K, Winklosky B, Perrin JM.Coury D, et al.Curr Opin Pediatr. 2009 Dec;21(6):828-32. doi: 10.1097/MOP.0b013e328331eaaa.Curr Opin Pediatr. 2009.PMID:19745738Review.
Cited by
- Long-lived epigenetic interactions between perinatal PBDE exposure and Mecp2308 mutation.Woods R, Vallero RO, Golub MS, Suarez JK, Ta TA, Yasui DH, Chi LH, Kostyniak PJ, Pessah IN, Berman RF, LaSalle JM.Woods R, et al.Hum Mol Genet. 2012 Jun 1;21(11):2399-411. doi: 10.1093/hmg/dds046. Epub 2012 Feb 15.Hum Mol Genet. 2012.PMID:22343140Free PMC article.
- Potential impact of DSM-5 criteria on autism spectrum disorder prevalence estimates.Maenner MJ, Rice CE, Arneson CL, Cunniff C, Schieve LA, Carpenter LA, Van Naarden Braun K, Kirby RS, Bakian AV, Durkin MS.Maenner MJ, et al.JAMA Psychiatry. 2014 Mar;71(3):292-300. doi: 10.1001/jamapsychiatry.2013.3893.JAMA Psychiatry. 2014.PMID:24452504Free PMC article.
- Autism spectrum disorder prevalence and associations with air concentrations of lead, mercury, and arsenic.Dickerson AS, Rahbar MH, Bakian AV, Bilder DA, Harrington RA, Pettygrove S, Kirby RS, Durkin MS, Han I, Moyé LA 3rd, Pearson DA, Wingate MS, Zahorodny WM.Dickerson AS, et al.Environ Monit Assess. 2016 Jul;188(7):407. doi: 10.1007/s10661-016-5405-1. Epub 2016 Jun 14.Environ Monit Assess. 2016.PMID:27301968
- Validity of autism diagnoses using administrative health data.Dodds L, Spencer A, Shea S, Fell D, Armson BA, Allen AC, Bryson S.Dodds L, et al.Chronic Dis Can. 2009;29(3):102-7.Chronic Dis Can. 2009.PMID:19527568Free PMC article.
- Clinical assessment and management of toddlers with suspected autism spectrum disorder: insights from studies of high-risk infants.Zwaigenbaum L, Bryson S, Lord C, Rogers S, Carter A, Carver L, Chawarska K, Constantino J, Dawson G, Dobkins K, Fein D, Iverson J, Klin A, Landa R, Messinger D, Ozonoff S, Sigman M, Stone W, Tager-Flusberg H, Yirmiya N.Zwaigenbaum L, et al.Pediatrics. 2009 May;123(5):1383-91. doi: 10.1542/peds.2008-1606.Pediatrics. 2009.PMID:19403506Free PMC article.Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources